Recall
FDAHealthJuly 24, 2025

Cipla USA, Inc. — Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc

⚠️ Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 24, 2025

U.S. Nationwide.

What's affected?

Product
Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.
Lot code
4IB0519

Additional details

Lot#: 4IB0519, Exp. 04/30/2026

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 20352 packs (1x 200 MD).

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.